Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 16 | 2022 | 129 | 5.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 96 | 2.010 |
Why?
|
| Brain Ischemia | 2 | 2021 | 71 | 1.430 |
Why?
|
| Blood Pressure Determination | 2 | 2022 | 20 | 0.960 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2019 | 115 | 0.940 |
Why?
|
| Arterial Pressure | 1 | 2022 | 14 | 0.860 |
Why?
|
| Weather | 2 | 2019 | 18 | 0.850 |
Why?
|
| Subarachnoid Hemorrhage | 7 | 2019 | 67 | 0.820 |
Why?
|
| Hyperglycemia | 1 | 2020 | 34 | 0.760 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2020 | 4 | 0.760 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2022 | 1221 | 0.740 |
Why?
|
| Blood Glucose | 1 | 2020 | 112 | 0.730 |
Why?
|
| Blood | 1 | 2019 | 25 | 0.720 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 132 | 0.700 |
Why?
|
| Prospective Studies | 12 | 2021 | 1811 | 0.700 |
Why?
|
| Neuroimaging | 1 | 2019 | 136 | 0.670 |
Why?
|
| Disease Progression | 2 | 2020 | 787 | 0.620 |
Why?
|
| Blood Pressure | 2 | 2022 | 238 | 0.570 |
Why?
|
| Brain | 3 | 2021 | 1689 | 0.560 |
Why?
|
| Humans | 27 | 2022 | 29337 | 0.510 |
Why?
|
| Middle Aged | 17 | 2020 | 9823 | 0.400 |
Why?
|
| Risk Factors | 7 | 2020 | 2443 | 0.380 |
Why?
|
| Time Factors | 6 | 2020 | 1616 | 0.370 |
Why?
|
| Male | 20 | 2020 | 15621 | 0.360 |
Why?
|
| Atmospheric Pressure | 2 | 2019 | 12 | 0.350 |
Why?
|
| Female | 20 | 2020 | 16197 | 0.340 |
Why?
|
| Vasospasm, Intracranial | 3 | 2019 | 17 | 0.300 |
Why?
|
| Aged | 14 | 2020 | 9448 | 0.290 |
Why?
|
| Incidence | 2 | 2019 | 756 | 0.280 |
Why?
|
| Hospital Mortality | 3 | 2015 | 141 | 0.270 |
Why?
|
| Cerebral Infarction | 3 | 2016 | 152 | 0.240 |
Why?
|
| Adult | 9 | 2020 | 8601 | 0.240 |
Why?
|
| Radial Artery | 1 | 2022 | 10 | 0.220 |
Why?
|
| Brain Death | 2 | 2020 | 15 | 0.220 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 521 | 0.210 |
Why?
|
| Blindness | 1 | 2022 | 14 | 0.210 |
Why?
|
| Chicago | 3 | 2020 | 865 | 0.210 |
Why?
|
| Treatment Outcome | 5 | 2020 | 3478 | 0.200 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 1113 | 0.200 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 11 | 0.190 |
Why?
|
| Young Adult | 4 | 2020 | 1932 | 0.190 |
Why?
|
| Occupational Health | 1 | 2020 | 21 | 0.190 |
Why?
|
| Brain Edema | 1 | 2020 | 22 | 0.190 |
Why?
|
| Anticonvulsants | 2 | 2013 | 109 | 0.190 |
Why?
|
| Apnea | 1 | 2020 | 16 | 0.190 |
Why?
|
| Encephalocele | 1 | 2020 | 26 | 0.190 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 553 | 0.190 |
Why?
|
| Epilepsy | 2 | 2013 | 104 | 0.190 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 65 | 0.180 |
Why?
|
| Intracranial Thrombosis | 1 | 2019 | 6 | 0.180 |
Why?
|
| Endocarditis | 1 | 2019 | 8 | 0.180 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2019 | 11 | 0.180 |
Why?
|
| Prognosis | 2 | 2020 | 840 | 0.180 |
Why?
|
| Blood Platelets | 2 | 2009 | 49 | 0.180 |
Why?
|
| Hospitalization | 2 | 2020 | 317 | 0.180 |
Why?
|
| Temperature | 1 | 2018 | 76 | 0.170 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 4851 | 0.170 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 145 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 86 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 89 | 0.160 |
Why?
|
| Biomarkers | 1 | 2020 | 689 | 0.150 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1442 | 0.140 |
Why?
|
| Hypertension | 1 | 2018 | 266 | 0.140 |
Why?
|
| Hematoma, Subdural | 1 | 2013 | 9 | 0.120 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2013 | 8 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2020 | 3273 | 0.120 |
Why?
|
| Erythrocyte Transfusion | 2 | 2010 | 20 | 0.120 |
Why?
|
| Troponin I | 2 | 2013 | 11 | 0.120 |
Why?
|
| Community Health Centers | 1 | 2012 | 12 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 149 | 0.110 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 35 | 0.110 |
Why?
|
| Warfarin | 1 | 2012 | 37 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2012 | 100 | 0.100 |
Why?
|
| Hypoglycemia | 1 | 2010 | 14 | 0.090 |
Why?
|
| Hemoglobins | 1 | 2010 | 81 | 0.090 |
Why?
|
| Blood Platelet Disorders | 1 | 2009 | 2 | 0.090 |
Why?
|
| Critical Care | 2 | 2010 | 234 | 0.090 |
Why?
|
| Lateral Ventricles | 1 | 2009 | 7 | 0.090 |
Why?
|
| Phenytoin | 1 | 2009 | 16 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 221 | 0.090 |
Why?
|
| Anemia | 1 | 2010 | 97 | 0.090 |
Why?
|
| Blood Coagulation | 1 | 2009 | 21 | 0.090 |
Why?
|
| Acute Lung Injury | 1 | 2009 | 14 | 0.090 |
Why?
|
| Euthanasia, Passive | 1 | 2009 | 3 | 0.090 |
Why?
|
| Comorbidity | 3 | 2020 | 498 | 0.090 |
Why?
|
| Life Support Care | 1 | 2009 | 11 | 0.090 |
Why?
|
| Disability Evaluation | 1 | 2010 | 327 | 0.080 |
Why?
|
| Age Factors | 2 | 2020 | 843 | 0.070 |
Why?
|
| Recovery of Function | 2 | 2020 | 290 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2020 | 59 | 0.050 |
Why?
|
| Prevalence | 2 | 2013 | 487 | 0.050 |
Why?
|
| Vasoconstriction | 1 | 2019 | 24 | 0.050 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 24 | 0.050 |
Why?
|
| Cerebral Angiography | 1 | 2019 | 29 | 0.050 |
Why?
|
| Syndrome | 1 | 2019 | 82 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2009 | 49 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 75 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 350 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 149 | 0.040 |
Why?
|
| Aspirin | 2 | 2009 | 83 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 219 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 330 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 496 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 236 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 788 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2010 | 770 | 0.030 |
Why?
|
| Factor VIIa | 1 | 2012 | 9 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 23 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2013 | 209 | 0.030 |
Why?
|
| Plasma | 1 | 2012 | 34 | 0.030 |
Why?
|
| Radiography | 1 | 2013 | 678 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2014 | 679 | 0.030 |
Why?
|
| Registries | 1 | 2012 | 188 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2009 | 9 | 0.020 |
Why?
|
| Craniotomy | 1 | 2009 | 23 | 0.020 |
Why?
|
| Platelet Transfusion | 1 | 2009 | 6 | 0.020 |
Why?
|
| Fever | 1 | 2009 | 40 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 394 | 0.020 |
Why?
|
| Resuscitation Orders | 1 | 2009 | 6 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 138 | 0.020 |
Why?
|
| Cause of Death | 1 | 2009 | 65 | 0.020 |
Why?
|
| Death | 1 | 2009 | 48 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 364 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 298 | 0.020 |
Why?
|
| Acute Disease | 1 | 2009 | 226 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 407 | 0.020 |
Why?
|
| Myocardium | 1 | 2009 | 139 | 0.020 |
Why?
|
| Length of Stay | 1 | 2010 | 317 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 1830 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2009 | 1939 | 0.020 |
Why?
|